Journey Medical (DERM) Cost of Revenue (2020 - 2026)

Journey Medical's Cost of Revenue history runs 7 years deep, the most recent figure standing at $6.2 million for Q1 2026.

• Quarterly Cost of Revenue rose 29.81% year-over-year to $6.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $22.4 million (up 13.65% YoY) and the FY2025 annual result came in at $20.9 million, changed 0.22% from the prior year.
• Cost of Revenue was $6.2 million for Q1 2026 at Journey Medical, up from $5.4 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $8.2 million in Q1 2022 and bottomed at $2.2 million in Q4 2023.
• A 5-year average of $6.0 million and a median of $6.0 million in 2024 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 109.9% — and 2023, when it tumbled 70.87%.
• Journey Medical's Cost of Revenue stood at $7.7 million in 2022, then tumbled by 70.87% to $2.2 million in 2023, then surged by 108.19% to $4.7 million in 2024, then increased by 16.24% to $5.4 million in 2025, then rose by 14.3% to $6.2 million in 2026.
• Business Quant data shows DERM's Cost of Revenue at $6.2 million in Q1 2026, $5.4 million in Q4 2025, and $5.8 million in Q3 2025.